Diego Sánchez

8 May 2025

Aspanoa invests 120.000 euros to promote new immunotherapies for childhood cancer.

It will be distributed equally between two research projects. One is led by Diego Sánchez (IIS Aragón) and the other by Eva Gálvez (CSIC) and Ramón Hurtado (BIFI – Unizar). Immunotherapy is a treatment already being applied to some cancer patients, including children, when standard therapies are insufficient.
6 February, 2024

The IIS Aragón will be present at the Aspanoa institutional event for Childhood Cancer Day

Diego Sánchez, ARAID at the IIS Aragón and scientific director of the Advanced Therapies Unit of Aragón, will give one of the presentations of the day.